All posts in Breaking News
CEO Interview Series, Greg Rainey from CCI Performance
We have started a new interview series where we will be speaking one on one with the senior leaders in our industry. We hope that this will make OSN a think tank and a place where you can get real …
Gorsky to succeed Weldon as CEO of Johnson & Johnson
The board of directors of Johnson & Johnson has named Alex Gorsky chief executive officer of Johnson & Johnson effective April 26. Gorsky, currently vice chairman of the company’s
Turbulence Ahead
Good morning folks, this is your captain speaking. While here at AAOS, some big news was announced. No, no acquisitions that we are aware of. Yes, there are
OrthoSpineNews will be at AAOS
That's right! We will be at AAOS and looking to conduct interviews with senior leaders of emerging companies. If you have a technology that you would like to
P&G To Lay Off 1,600 After Discovering It’s Free To Advertise On Facebook Read more: http://www.businessinsider.com/pg-ceo-to-lay-off-1600-after-discovering-its-free-to-advertise-on-facebook-and-google-2012-1#ixzz1l3FEfe9c
On (and Off) the Record – RY Ortho
Dear OTW Reader: Has Dr. Javad Parvizi found THE solution for infection detection?…Applicant boom at HSS (and elsewhere)…James Lightman New VP at Wright…Are theresurprises in store for young orthopedists flocking to hospital employment?…and more.
New
Regen Biologics slams FDA for revoking Menaflex approval
Regen Biologics blasted the Food and Drug Administration Monday for its decision to revoke its 2-year-old approval of the company’s leading product, a patch to repair the knee’s
FDA Rescinds Approval of Menaflex Knee Replacement Device
The FDA has rescinded approval for the Menaflex Collagen Scaffold knee replacement, saying that the orthopedic implant was incorrectly fast-tracked for approval without being appropriately vetted by the
OSN Launches Job Board
OrthoSpineNews is proud to release a new job board!! We have seen steady growth in our readership and are now serving news to approximately 10,000 people per month!!!
Pound for Pound
This has been an interesting week in Spine/Biologics. You may remember when Ramius decided to go on the offensive against Orthofix last year regarding the perceived mismanagement/acquisition of
Don’t Call it a Comeback…
I have had the great joy to post a great many articles in recent weeks announcing money raised for multiple early stage companies in our space. I wanted
Predictability Competes with Confidence in 510(k) Revamp
Assuaging both agency and industry concerns requires a precarious balancing act in the 510(k) overhaul. By: James G. Dickinson FDA’s massive revamp of its battered 510(k) market-entry program for medical